Acute tubular necrosis associated with chromium picolinate-containing dietary supplement

Annals of Pharmacotherapy

Volumn 40, Issue 3, 2006, Pages 563-566

  Wani, Sachin ^a,b   Weskamp, Celia ^a,c   Marple, Jeffrey ^d   Spry, Leslie ^b,d  

^a Bryan LGH Medical Center   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF PHARMACY AND HEALTH PROFESSIONS   (United States)

^d Lincoln Nephrology & Hypertension Nebraska   (United States)

Author keywords

Acute renal failure; Chromium picolinate; Dietary supplement

Indexed keywords

ARSENAL X; CHROMIUM PICOLINATE; GUARANA; HERBACEOUS AGENT; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; DISEASE COURSE; DOSE TIME EFFECT RELATION; HUMAN; KIDNEY BIOPSY; MALE; NEPHROTOXICITY; OUTPATIENT; PAULLINIA; PLASMAPHERESIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROBABILITY; RENOGRAPHY; SIDA CORDIFOLIA; STEROID THERAPY; UNITED STATES;

ADULT; ANTI-INFLAMMATORY AGENTS; DIETARY SUPPLEMENTS; HUMANS; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; PICOLINIC ACIDS; PLASMAPHERESIS; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645064813     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G469     Document Type: Article

References (23)

1. Bauer BA. Herbal therapy: what a clinician needs to know to counsel patients effectively. Mayo Clin Proc 2000;75:835-41.
2. Nielsen FH. Chromium. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1994:264-8.
3. Katz SA, Salem H. The toxicology of chromium with respect to its chemical speciation: a review. J Appl Toxicol 1993;13:217-24.
4. van Heerden PV, Jenkins IR, Woods WPD, Rossi E, Cameron PD. Death by tanning - a case of fatal basic chromium sulphate poisoning. Intensive Care Med 1994;20:145-7.
5. Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab 2000;26:22-7.
6. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term parenteral nutrition. Am J Clin Nutr 1977;30:531-8.
7. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term parenteral nutrition. Dig Dis Sci 1986;31:661-4.
8. Mertz W. Chromium in human nutrition: a review. J Nutr 1993;123:626-33.
9. Morris BW, Kouta S, Robinson R, MacNeil S, Heller S. Chromium supplementation improves insulin resistance in patients with type 2 diabetes mellitus. Diabet Med 2000;17:684-5.
10. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 2002;132:1107-14.
11. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as nutrient supplement. Food Chem Toxicol 2004;42:1029-42.
12. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786-91.
13. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994;17:1449-52.
14. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res 2000;33:503-10.
15. Wasser WG, Yusuf SA, D'Agati VD. Over-the-counter chromium and renal failure (letter). Ann Intern Med 1997;127:656.
16. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31. DOI 10.1345/aph.17327
17. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-2.
18. Stearns DM, Wise JP, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J 1995;9:1643-8.
19. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002;180:5-22.
20. Brenner BM, Mackenzie HS. Nephron mass as a risk factor for progression of renal disease. Kidney Int 1997;52(suppl 63):S124-7.
21. Brenner BM, Lawler E, Mackenzie H. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996;49:1774-7.
22. Zalups RK. Reductions in renal mass and the nephropathy induced by mercury. Toxicol Appl Pharmacol 1997;143:366-79.
23. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.